Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

130.23 +1.71 (+1.33%)
Streaming Delayed Price Updated: 11:47 AM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
87 88 Next >
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
Novavax shares sank 93% last year. 
Via The Motley Fool
This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now
Moderna stock has dropped 60% from its peak. 
Via The Motley Fool
Why BioNTech And Moderna Shares Are Falling After Pfizer News
BioNTech SE - ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) shares are trading lower Tuesday morning in sympathy with Pfizer Inc. (NYSE: 
Via Benzinga
Biden Administration Plans To End COVID-19 Public Health Emergency In May
 
Via Benzinga
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths. 
Via Benzinga
Could This RSV News Make Moderna a Hot Buy Again?
The company could soon have a new vaccine bringing in revenue. 
Via The Motley Fool
What 10 Analyst Ratings Have To Say About Moderna
 
Via Benzinga
Here's the Worst Mistake Novavax Investors Can Make in 2023
Can Novavax still win over the long term? 
Via The Motley Fool
The RSV Vaccine Battle Wages On With Moderna Scoring A Win Vs. Pfizer, GSK
But Moderna stock didn't move higher on the announcement. 
Via Investor's Business Daily
2 Struggling Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
Two of these stocks have what it takes to rebound and deliver lasting gains. 
Via The Motley Fool
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
The FDA's experts voted in favor of annual boosters on Thursday. 
Via Investor's Business Daily
The 3 Best Biotech Stocks Under $1 to Buy for January
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich. 
Via InvestorPlace
2 Top Biotech Stocks to Buy for the Long Haul
Developing new products will be key to the success of both of these biotech leaders. 
Via The Motley Fool
Thursday Predictions: 3 Hot Stocks for Tomorrow
Airline stocks, credit card stocks, and vaccine stocks are our focus when it comes to the hot stocks for tomorrow. Here's why. 
Via InvestorPlace
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength. 
Via Talk Markets
Moderna, Kellogg And 2 Other Stocks Insiders Are Selling
The Nasdaq settled higher on Friday, also notching gains for the week. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
COVID, Shmovid: This Could Be the Next Big Growth Story for Moderna Stock
Moderna could follow closely behind Pfizer and GSK in entering the lucrative RSV vaccine market. 
Via The Motley Fool
Stock Market Rally Pulls Back; Microsoft, Google Slash Jobs; Netflix, Goldman, Tesla In Focus: Weekly Review
Microsoft and Google are slashing jobs. Netflix and Tesla jumped. 
Via Investor's Business Daily
2 Nasdaq 100 Stocks to Buy Hand Over Fist in 2023 and 1 to Avoid Like the Plague
The growth-driven Nasdaq 100 is home to two incredible deals in the new year, as well as one previous highflier that can be actively avoided. 
Via The Motley Fool
Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market
After years of lab failures, the companies could crack open a multibillion-dollar market. 
Via Investor's Business Daily
Volatility In Markets Increases, Dow Tumbles Over 600 Points
The S&P 500 fell more than 1.5% on Wednesday, recording biggest daily decline in more than one month following weak economic data. US economic reports released Wednesday showed retail sales and... 
Via Benzinga
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+... 
Via Benzinga
Why Is Zomedica (ZOM) Stock Up Today?
Zomedica (ZOM) stock is on the rise Wednesday after the company signed a strategic restructuring agreement with Qorvo Biotechnologies. 
Via InvestorPlace
Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results
Moderna (MRNA) stock is on the move Wednesday alongside positive results from its latest Phase 3 mRNA-1345 vaccine trial. 
Via InvestorPlace
Moderna Gets Good News, but Another Biotech Stock Is Falling Again
The Nasdaq looked poised for modest gains once again on Wednesday. 
Via The Motley Fool
What's Going On With Moderna Stock Today?
Moderna Inc (NASDAQ: MRNA) shares are trading higher Wednesday after the company's respiratory syncytial virus (RSV) vaccine candidate met its primary endpoint in a 
Via Benzinga
Alphabet To Rally Around 37%? Here Are 10 Other Analyst Forecasts For Wednesday
Morgan Stanley cut the price target for IBM (NYSE: IBM) from $152 to $148. Morgan Stanley analyst Erik Woodring downgraded the stock from Overweight to Equal-Weight. IBM shares fell 2.3% to $141.80 in... 
Via Benzinga
Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) rose 41.5% to $0.3255 in pre-market trading after gaining 8% on Tuesday. 
Via Benzinga
Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today
Moderna, Inc. (NASDAQ: MRNA) shares were solidly higher in premarket trading on Wednesday. 
Via Benzinga
US Stocks Flat Ahead Of Data Deluge — But Analysts Says Investors May Be In For A Surprise As Earnings Pessimism Overdone
U.S. stocks may get off to a nervous start on Wednesday, as apprehensions concerning fourth-quarter earnings and the state of the economy continue to weigh down. 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
87 88 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.